Cite

HARVARD Citation

    Jung, S. et al. (2021). Palbociclib with letrozole as second-line neo-systemic therapy after failure of neo-adjuvant chemotherapy for luminal type breast cancer. Medicine. 100 (14), p. . [Online]. 
  
Back to record